Why do international patients consider India for fertility treatment?
India is often considered for its large private fertility sector, substantial clinical volume, specialist availability, and potentially lower treatment costs. Suitability depends on current eligibility rules, clinic governance, laboratory quality, documentation, travel requirements, and continuity-of-care planning.
Are all fertility pathways available to international patients in India?
No. Treatment eligibility, donor pathways, surrogacy access, relationship-status requirements, documentation, and clinic policies may be restricted or subject to change. The proposed pathway should be confirmed before deposits, medication orders, or travel bookings.
Does FertilityCareHub recommend specific fertility clinics in India?
FertilityCareHub does not publish public best-clinic rankings or paid promotional lists. Private advisory may include a curated shortlist based on licensing, medical leadership, laboratory governance, embryology continuity, communication, cost transparency, and international-patient coordination.
How should fertility-clinic success rates in India be evaluated?
Success rates should be reviewed by treatment type, age group, donor use where relevant, patient population, denominator, reporting period, and outcome endpoint. Patients should distinguish pregnancy rates from live-birth rates and confirm whether results are reported per cycle started, retrieval, transfer, or cumulative pathway.
What costs should be considered beyond an Indian clinic package price?
A complete estimate should include medication, testing, monitoring, laboratory procedures, donor services where applicable, freezing, storage, embryo transfer, additional consultations, travel, accommodation, local transportation, translation where needed, cancellation exposure, and possible repeat treatment.